Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)

· Jiangsu Province Centers for Disease Control and Prevention

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells), covering 2022-06-01 to 2022-06-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) [Phase 2]

See pricing